CUE Cue Biopharma, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $117.1M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $3.5M | $0 |
| 2022-Q2 | $816.7K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $30.6K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $19.6K | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $30.9K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $99.7K | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $2.0M |
| 2026-Q4 | $0 | $389.3K |
Bought$4.5M8 buy days
Sold$3.0M11 sell days
Net insider flow+$1.5Mnet buying · 5 years
Latest trade2026-10-12Lin Shao-Lee
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Sell | Lin Shao-Lee | CEO | 11,087 | $27.55 | $305.5K | 2 |
| 2026-10-12 | Sell | Ray Sumita | Other C-suite | 1,844 | $28.05 | $51.7K | 1 |
| 2026-10-12 | Sell | Meluzio Michael Vincent | VP | 1,144 | $28.05 | $32.1K | 1 |
| 2026-08-13 | Sell | Lin Shao-Lee | CEO | 18,258 | $28.62 | $522.6K | 3 |
| 2026-08-13 | Sell | Ray Sumita | Other C-suite | 8,829 | $30.09 | $265.6K | 3 |
| 2026-08-13 | Sell | Meluzio Michael Vincent | VP | 5,628 | $30.09 | $169.3K | 3 |
| 2026-08-12 | Sell | Lin Shao-Lee | CEO | 40,000 | $27.10 | $1.1M | 2 |
| 2025-12-30 | Buy | Sarraf Pasha | Director | 323,857 | $0.31 | $99.7K | 5 |
| 2024-12-16 | Buy | PASSERI DANIEL R | CEO | 30,000 | $1.03 | $30.9K | 1 |
| 2023-08-25 | Buy | Suri Anish | President | 4,000 | $2.76 | $11.0K | 1 |
| 2023-08-14 | Buy | PASSERI DANIEL R | CEO | 3,000 | $2.86 | $8.6K | 1 |
| 2023-03-23 | Sell | Kiener Peter A | Director | 9,325 | $3.28 | $30.6K | 1 |
| 2022-05-27 | Buy | Morich Frank | Director | 28,000 | $3.75 | $105.0K | 1 |
| 2022-05-24 | Buy | Fletcher Aaron G.L. | Director | 55,000 | $3.34 | $183.7K | 1 |
| 2022-05-23 | Buy | Fletcher Aaron G.L. | Director | 150,000 | $3.52 | $528.0K | 1 |
| 2022-03-31 | Buy | Fletcher Aaron G.L. | Director | 735,000 | $4.76 | $3.5M | 1 |
| 2021-11-16 | Sell | Kiener Peter A | Director | 1,361 | $18.02 | $24.5K | 1 |
| 2021-11-15 | Sell | Kiener Peter A | Director | 18,815 | $17.92 | $337.2K | 1 |
| 2021-11-15 | Sell | Suri Anish | President | 8,000 | $18.05 | $144.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Fletcher Aaron G.L. | Director | $4.2M | $0 | 2022-05-24 |
| Lin Shao-Lee | CEO | $0 | $1.9M | 2026-10-12 |
| Kiener Peter A | Director | $0 | $392.3K | 2023-03-23 |
| Ray Sumita | Other C-suite | $0 | $317.4K | 2026-10-12 |
| Meluzio Michael Vincent | VP | $0 | $201.4K | 2026-10-12 |
| Suri Anish | President | $11.0K | $144.4K | 2023-08-25 |
| Morich Frank | Director | $105.0K | $0 | 2022-05-27 |
| Sarraf Pasha | Director | $99.7K | $0 | 2025-12-30 |
| PASSERI DANIEL R | CEO | $39.5K | $0 | 2024-12-16 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2018-12-11 → 2018-12-31 | 3 | $747.4K | 49 | +0.9% (+13.1% raw) | +59.9% (+77.7% raw) | +86.6% (+106.7% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.